{"id":"W4407976072","doi":"10.3390/jcm14051561","title":"Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease","year":2025,"lang":"en","type":"review","venue":"Journal of Clinical Medicine","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Hexal AG","keywords":"Biosimilar; Medicine; Inflammatory bowel disease; Intensive care medicine; Infliximab; Tumor necrosis factor alpha; Disease; Formulary; Crohn's disease; Immunology; Pharmacology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001183409,0.0005457654,0.001063201,0.002267688,0.0001947416,0.0008250794,0.0007249853,0.001332051,0.002869897],"category_scores_gemma":[0.001596407,0.0002528953,0.000754672,0.001801102,0.000327279,0.0009395016,0.0005216467,0.00138862,0.001254385],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000629039,"about_ca_system_score_gemma":0.001451204,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001066531,"about_ca_topic_score_gemma":0.002124544,"domain_scores_codex":[0.9995613,0.0001173251,0.00007401604,0.00004876445,0.0001670991,0.00003154721],"domain_scores_gemma":[0.9992692,0.0003883589,0.0001108518,0.00001623533,0.0001796814,0.00003573628],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00008720285,0.0000510383,0.0001375593,0.03064234,0.0001489585,0.0001156393,0.00005873245,0.0003042269,0.001281171,0.003177332,0.01975816,0.9442376],"study_design_scores_gemma":[0.0000486526,0.0001433,0.001166746,0.01157781,0.0002399726,0.001059205,0.00006368477,0.000130545,0.0005948241,0.001426826,0.9835316,0.00001686878],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001157973,0.9986516,0.00008113011,0.0002935737,0.0001318593,0.000005344699,0.00001106894,0.000004483518,0.0007051839],"genre_scores_gemma":[0.0007415977,0.998583,0.0001574348,0.0001885186,0.00006773433,0.000006133691,0.0000142471,8.822796e-7,0.000240423],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002869897,"threshold_uncertainty_score":0.009600759,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.168548071039021,"score_gpt":0.4946549485358143,"score_spread":0.3261068774967933,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}